Sodium Tetradecyl Sulfate Sclerotherapy for Venous Malformation of the Tongue: A Single-Center Experience

Abstract

Purpose To study the safety and effectiveness of sclerotherapy with 3% sodium tetradecyl sulfate (STS) in the management of venous malformation (VM) of the tongue.

Materials and Methods The clinical and imaging data of patients with tongue VM treated with STS sclerotherapy over a period of 15 years (2002–2017) were reviewed. Safety was assessed based on the incidence of minor and major complications. Effectiveness was assessed by clinical improvement (reduction in symptoms and size) on a 10-point scale.

Results The study included 44 patients (26 men and 18 women). The median age was 24 years at the time of treatment. Eight patients were lost to follow-up. Four patients (4 of 44, 9%) had complications including venous bleeding needing compression, self-limiting hematuria, significant swelling of the tongue requiring prolonged intubation, and arterial bleeding due to injury to the lingual artery. Clinical improvement was seen in 30 (30 of 36, 83%). The median clinical improvement was 4.5 on the 10-point scale, with a range of 1 to 8. Twelve (12 of 36, 33.3%) patients demonstrated 1 to 40% improvement in the lesion size and 18 (50%) had 41 to 80% improvement.

Conclusion Sclerotherapy with 3% STS is safe and effective in treating venous malformations of the tongue with minimal complications.

Keywords

tongue venous malformation - sclerotherapy - sodium tetradecyl sulfate

• References

• 1 Spence J, Krings T, terBrugge KG, da Costa LB, Agid R. Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results. AJNR Am J Neuroradiol 2010; 31 (05) 955-960
• 2 Zheng JW, Mai HM, Zhang L. et al. Guidelines for the treatment of head and neck venous malformations. Int J Clin Exp Med 2013; 6 (05) 377-389
• 3 de Lorimier AA. Sclerotherapy for venous malformations. J Pediatr Surg 1995; 30 (02) 188-193 discussion 194
• 4 Mulliken JB, Young AE. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia, PA: Saunders; 1988
• 5 Sitra G, Kayalvizhi EB, Sivasankari T, Vishwanath R. A new venture with sclerotherapy in an oral vascular lesion. J Basic Clin Pharm 2014; 6 (01) 40-43
• 6 Johnson PL, Eckard DA, Brecheisen MA, Girod DA, Tsue TT. Percutaneous ethanol sclerotherapy of venous malformations of the tongue. AJNR Am J Neuroradiol 2002; 23 (05) 779-782
• 7 Duffy DM. Sclerosants: a comparative review. Dermatol Surg 2010; 36 (Suppl. 02) 1010-1025
• 8 Pappas Jr DC, Persky MS, Berenstein A. Evaluation and treatment of head and neck venous vascular malformations. Ear Nose Throat J 1998; 77 (11) 914-916 918–922
• 9 Wiegand S, Eivazi B, Zimmermann AP, Sesterhenn AM, Werner JA. Sclerotherapy of lymphangiomas of the head and neck. Head Neck 2011; 33 (11) 1649-1655
• 10 Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27 (01) 58-60
• 11 Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003; 14 (09) Pt 2 S199-S202
• 12 Alakailly X, Kummoona R, Quereshy FA, Baur DA, González AE. The use of sodium tetradecyl sulphate for the treatment of venous malformations of the head and neck. J Maxillofac Oral Surg 2015; 14 (02) 332-338
• 13 Ul Haq F, Mitchell SE, Tekes A, Weiss CR. Bleomycin foam treatment of venous malformations: a promising agent for effective treatment with minimal swelling. J Vasc Interv Radiol 2015; 26 (10) 1484-1493
• 14 Horbach SE, Lokhorst MM, Saeed P, de Goüyon Matignon, de Pontouraude CM, Rothová A, van der Horst CM. Sclerotherapy for low flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg 2016; 69 (03) 295-304
• 15 Bourgouin P, Thomas-Chaussé F, Gilbert P. et al. Effectiveness and safety of sclerotherapy for treatment of low-flow vascular malformations of the oropharyngeal region. J Vasc Interv Radiol 2018; 29 (06) 809-815
• 16 Chen G, Cai X, Ren JG, Jia J, Zhao YF. Unexpected development of tongue squamous cell carcinoma after sclerotherapy for the venous malformation: a unique case report and literature review. Diagn Pathol 2013; 8: 182
• 17 Shah KM, Karagir A, Adaki S. Slow-flow-type venous malformation of tongue. BMJ Case Rep 2013; 2013: bcr2013008945